Physician profile
Tracey Wright
NPI 1831495795
$2,843.63
in general payments reported to CMS, 2019-2025
23 companies · $416 in 2025
The $416 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $611 · 2022: $510 · 2023: $600 · 2024: $707 · 2025: $416.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,723.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,723.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $426.60 | 2021-2025 | Repatha |
| Boston Scientific Corporation | $277.84 | 2021-2024 | Watchman Flx |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $249.79 | 2021-2024 | Lifevest |
| Astrazeneca Pharmaceuticals Lp | $246.94 | 2021-2025 | Farxiga, Brilinta |
| Actelion Pharmaceuticals US, INC. | $219.91 | 2023-2024 | Opsumit, Uptravi |
| Novartis Pharmaceuticals Corporation | $210.93 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $168.04 | 2021-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $162.47 | 2021-2024 | Jardiance |
| Bridgebio Pharma, INC. | $134.63 | 2025 | Attruby |
| Sanofi-Aventis U.S. LLC | $126.94 | 2022-2023 | |
| Pfizer INC. | $82.83 | 2022-2025 | |
| Esperion Therapeutics, INC. | $81.92 | 2021-2023 | Nexletol |
| Merck Sharp & Dohme LLC | $81.77 | 2023-2024 | Verquvo, Winrevair, Belsomra |
| E.R. Squibb & Sons, L.L.C. | $66.33 | 2021-2025 | Eliquis |
| Novo Nordisk INC | $61.19 | 2025 | Wegovy |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $54.75 | 2022-2024 | Camzyos |
| Abbott Laboratories | $50.10 | 2023-2025 | Gallant, Triclip |
| Regeneron Healthcare Solutions, INC. | $40.34 | 2023 | Evkeeza |
| Impulse Dynamics (USA) INC. | $36.51 | 2022 | |
| Kestra Medical Technology Services, INC. | $19.00 | 2023 | Assure Wcd |
| Lexicon Pharmaceuticals, INC. | $16.72 | 2023 | Inpefa |
| Coastal Medical Technologies LLC | $16.19 | 2023 | |
| Gilead Sciences, INC. | $11.89 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracey Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.